
Beximco Pharmaceuticals Ltd
93 / Per 30 Capsule
It is indicated in the regular treatment of asthma, where the use of a combination (long‐acting, beta2‐agonist and inhaled corticosteroid) has been found to be appropriate. It is also indicated in the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD), with a history of repeated exacerbations despite regular therapy with long‐acting bronchodilators.
Login To Review